| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 71 | 2024 | 1065 | 5.810 |
Why?
|
| Erythrocytes | 107 | 2024 | 2418 | 5.250 |
Why?
|
| Reticulocytes | 29 | 2022 | 287 | 3.430 |
Why?
|
| Anemia, Iron-Deficiency | 17 | 2024 | 372 | 3.050 |
Why?
|
| Symporters | 30 | 2022 | 363 | 2.780 |
Why?
|
| Potassium | 61 | 2022 | 1315 | 2.460 |
Why?
|
| Erythrocytes, Abnormal | 18 | 2018 | 121 | 1.950 |
Why?
|
| Erythrocyte Membrane | 32 | 2015 | 438 | 1.930 |
Why?
|
| Hemoglobins | 34 | 2021 | 1531 | 1.920 |
Why?
|
| beta-Thalassemia | 13 | 2023 | 234 | 1.900 |
Why?
|
| Hematology | 4 | 2024 | 243 | 1.510 |
Why?
|
| Intermediate-Conductance Calcium-Activated Potassium Channels | 13 | 2022 | 45 | 1.410 |
Why?
|
| Clotrimazole | 22 | 2008 | 76 | 1.380 |
Why?
|
| Erythropoiesis | 18 | 2018 | 691 | 1.380 |
Why?
|
| Editorial Policies | 16 | 2016 | 458 | 1.370 |
Why?
|
| Chlorides | 30 | 2022 | 666 | 1.320 |
Why?
|
| Blood Cell Count | 6 | 2021 | 406 | 1.130 |
Why?
|
| Erythrocyte Indices | 18 | 2019 | 143 | 1.100 |
Why?
|
| Hemoglobin, Sickle | 17 | 2022 | 113 | 1.070 |
Why?
|
| Anemia, Hemolytic, Congenital | 9 | 2019 | 71 | 1.060 |
Why?
|
| Hydrops Fetalis | 9 | 2019 | 113 | 1.040 |
Why?
|
| Erythropoietin | 21 | 2006 | 718 | 1.030 |
Why?
|
| Hematologic Diseases | 4 | 2021 | 498 | 1.030 |
Why?
|
| Ion Transport | 18 | 2017 | 322 | 1.010 |
Why?
|
| Magnesium | 14 | 2011 | 815 | 1.000 |
Why?
|
| Reticulocyte Count | 14 | 2021 | 36 | 0.990 |
Why?
|
| Automation, Laboratory | 2 | 2024 | 102 | 0.980 |
Why?
|
| Iron | 21 | 2023 | 1813 | 0.950 |
Why?
|
| Glycine Plasma Membrane Transport Proteins | 2 | 2021 | 21 | 0.930 |
Why?
|
| Hydroxyurea | 14 | 2021 | 284 | 0.910 |
Why?
|
| Potassium Channels, Calcium-Activated | 7 | 2005 | 43 | 0.850 |
Why?
|
| Cations | 13 | 2022 | 240 | 0.850 |
Why?
|
| Spherocytosis, Hereditary | 9 | 2024 | 83 | 0.820 |
Why?
|
| Antisickling Agents | 9 | 2014 | 72 | 0.760 |
Why?
|
| Journalism, Medical | 4 | 2016 | 73 | 0.760 |
Why?
|
| Hemolysis | 13 | 2021 | 417 | 0.760 |
Why?
|
| Sulfones | 2 | 2021 | 448 | 0.750 |
Why?
|
| Iron Compounds | 1 | 2021 | 28 | 0.750 |
Why?
|
| Potassium Channels | 17 | 1999 | 538 | 0.740 |
Why?
|
| Sodium | 29 | 2013 | 1597 | 0.740 |
Why?
|
| Potassium Channel Blockers | 8 | 2017 | 162 | 0.700 |
Why?
|
| Adenoidectomy | 2 | 2020 | 171 | 0.680 |
Why?
|
| Anion Exchange Protein 1, Erythrocyte | 11 | 2011 | 150 | 0.660 |
Why?
|
| Acetamides | 5 | 2021 | 259 | 0.640 |
Why?
|
| Periodicals as Topic | 8 | 2016 | 1465 | 0.610 |
Why?
|
| Erythrocyte Count | 11 | 2021 | 157 | 0.610 |
Why?
|
| Tonsillectomy | 2 | 2020 | 281 | 0.600 |
Why?
|
| Specimen Handling | 10 | 2014 | 708 | 0.600 |
Why?
|
| Postoperative Hemorrhage | 2 | 2020 | 419 | 0.580 |
Why?
|
| Calcium | 25 | 2010 | 5792 | 0.570 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 381 | 0.570 |
Why?
|
| Carrier Proteins | 22 | 2019 | 4937 | 0.550 |
Why?
|
| Anemia, Hypochromic | 3 | 2015 | 62 | 0.550 |
Why?
|
| Piperazines | 4 | 2023 | 2554 | 0.540 |
Why?
|
| Ion Channels | 12 | 2019 | 1043 | 0.520 |
Why?
|
| Anemia, Hemolytic | 4 | 2023 | 164 | 0.510 |
Why?
|
| Disclosure | 9 | 2012 | 755 | 0.490 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2015 | 87 | 0.480 |
Why?
|
| Biological Transport | 33 | 2015 | 2085 | 0.460 |
Why?
|
| Fetal Hemoglobin | 14 | 2023 | 346 | 0.460 |
Why?
|
| Blood Proteins | 5 | 2012 | 1191 | 0.460 |
Why?
|
| Pyrrolidonecarboxylic Acid | 4 | 2007 | 66 | 0.450 |
Why?
|
| Blood Chemical Analysis | 2 | 2014 | 435 | 0.450 |
Why?
|
| Dehydration | 10 | 2019 | 216 | 0.450 |
Why?
|
| Water-Electrolyte Balance | 9 | 2001 | 326 | 0.440 |
Why?
|
| von Willebrand Diseases | 1 | 2015 | 135 | 0.430 |
Why?
|
| Point-of-Care Systems | 2 | 2021 | 1238 | 0.420 |
Why?
|
| Phosphoprotein Phosphatases | 5 | 2005 | 327 | 0.410 |
Why?
|
| Quantitative Trait Loci | 6 | 2017 | 2131 | 0.400 |
Why?
|
| Hemoglobin SC Disease | 5 | 2022 | 23 | 0.400 |
Why?
|
| Anemia | 10 | 2019 | 1514 | 0.400 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 5 | 2010 | 59 | 0.390 |
Why?
|
| Humans | 222 | 2024 | 768166 | 0.380 |
Why?
|
| Antiporters | 5 | 2004 | 276 | 0.370 |
Why?
|
| von Willebrand Factor | 1 | 2015 | 680 | 0.360 |
Why?
|
| Mice | 76 | 2024 | 82029 | 0.360 |
Why?
|
| Ferritins | 10 | 2021 | 601 | 0.350 |
Why?
|
| Clinical Medicine | 4 | 2012 | 145 | 0.350 |
Why?
|
| Clinical Laboratory Techniques | 6 | 2012 | 747 | 0.340 |
Why?
|
| Hematologic Tests | 5 | 2024 | 239 | 0.340 |
Why?
|
| Chromosomes, Mammalian | 1 | 2010 | 148 | 0.340 |
Why?
|
| beta-Globins | 1 | 2010 | 111 | 0.340 |
Why?
|
| Animals | 104 | 2024 | 169246 | 0.340 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 13 | 2013 | 480 | 0.330 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 4 | 1 | 2008 | 8 | 0.320 |
Why?
|
| Reference Values | 15 | 2021 | 4938 | 0.310 |
Why?
|
| Reperfusion Injury | 2 | 2024 | 1039 | 0.300 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2000 | 279 | 0.290 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2008 | 37 | 0.290 |
Why?
|
| Automation | 2 | 2024 | 589 | 0.290 |
Why?
|
| Mutation, Missense | 6 | 2019 | 2592 | 0.290 |
Why?
|
| Hydrogen-Ion Concentration | 15 | 2022 | 2486 | 0.290 |
Why?
|
| Erythroblasts | 4 | 2014 | 142 | 0.290 |
Why?
|
| Forkhead Transcription Factors | 4 | 2021 | 1625 | 0.290 |
Why?
|
| Disease Models, Animal | 26 | 2024 | 18349 | 0.280 |
Why?
|
| Spherocytes | 2 | 2012 | 9 | 0.280 |
Why?
|
| Hyperkalemia | 3 | 2016 | 234 | 0.280 |
Why?
|
| Erythrocyte Volume | 6 | 2007 | 28 | 0.280 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 213 | 0.280 |
Why?
|
| Ethylmaleimide | 5 | 2001 | 69 | 0.270 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2665 | 0.270 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2008 | 352 | 0.270 |
Why?
|
| Genomics | 2 | 2021 | 5926 | 0.260 |
Why?
|
| Nitroso Compounds | 1 | 2006 | 71 | 0.260 |
Why?
|
| Multiple Myeloma | 2 | 2023 | 5196 | 0.260 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2006 | 64 | 0.260 |
Why?
|
| Osmotic Fragility | 8 | 2019 | 35 | 0.250 |
Why?
|
| Serum Albumin, Bovine | 1 | 2006 | 320 | 0.250 |
Why?
|
| Hematinics | 1 | 2008 | 282 | 0.240 |
Why?
|
| Scorpion Venoms | 2 | 1995 | 30 | 0.240 |
Why?
|
| Haplotypes | 2 | 2010 | 2722 | 0.230 |
Why?
|
| Mice, Transgenic | 18 | 2021 | 9561 | 0.230 |
Why?
|
| Osmolar Concentration | 8 | 2006 | 657 | 0.230 |
Why?
|
| Torque teno virus | 1 | 2024 | 13 | 0.230 |
Why?
|
| Plasmodium knowlesi | 2 | 2015 | 23 | 0.230 |
Why?
|
| Dietary Supplements | 5 | 2017 | 3445 | 0.230 |
Why?
|
| Cell Size | 8 | 2019 | 626 | 0.230 |
Why?
|
| Administration, Oral | 11 | 2021 | 4030 | 0.230 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2008 | 801 | 0.220 |
Why?
|
| Genetic Variation | 6 | 2017 | 6611 | 0.220 |
Why?
|
| Iron Overload | 2 | 2023 | 245 | 0.220 |
Why?
|
| Hematocrit | 14 | 2012 | 623 | 0.220 |
Why?
|
| Membrane Proteins | 10 | 2014 | 7876 | 0.220 |
Why?
|
| Transferrin | 4 | 2021 | 283 | 0.220 |
Why?
|
| Doping in Sports | 2 | 2000 | 62 | 0.220 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 3706 | 0.210 |
Why?
|
| alpha-Thalassemia | 2 | 2014 | 53 | 0.210 |
Why?
|
| Pyruvate Kinase | 2 | 2023 | 191 | 0.210 |
Why?
|
| Potassium Chloride | 2 | 2003 | 229 | 0.210 |
Why?
|
| Administrative Personnel | 2 | 1994 | 185 | 0.210 |
Why?
|
| Conflict of Interest | 4 | 2011 | 556 | 0.210 |
Why?
|
| Hemoglobin C Disease | 3 | 1989 | 8 | 0.210 |
Why?
|
| Antifungal Agents | 6 | 1997 | 761 | 0.210 |
Why?
|
| Receptors, Erythropoietin | 2 | 2022 | 144 | 0.200 |
Why?
|
| Recombinant Proteins | 18 | 2004 | 6514 | 0.200 |
Why?
|
| Vasodilator Agents | 2 | 2006 | 990 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2007 | 3139 | 0.200 |
Why?
|
| Ouabain | 10 | 2011 | 246 | 0.200 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 7 | 2006 | 106 | 0.200 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2024 | 249 | 0.200 |
Why?
|
| Bumetanide | 8 | 2006 | 101 | 0.200 |
Why?
|
| Male | 83 | 2024 | 364719 | 0.200 |
Why?
|
| Hydrocephalus | 2 | 2000 | 768 | 0.200 |
Why?
|
| Cell Count | 5 | 2017 | 1832 | 0.200 |
Why?
|
| Erythrocyte Aging | 5 | 2012 | 52 | 0.200 |
Why?
|
| Athletes | 2 | 2021 | 1162 | 0.200 |
Why?
|
| Calpain | 2 | 2012 | 146 | 0.200 |
Why?
|
| Infusions, Intravenous | 3 | 2021 | 2230 | 0.190 |
Why?
|
| Erythrocyte Deformability | 5 | 2017 | 55 | 0.190 |
Why?
|
| Nitric Oxide | 4 | 2006 | 2146 | 0.190 |
Why?
|
| Calcium Channel Blockers | 3 | 2002 | 687 | 0.190 |
Why?
|
| DNA Virus Infections | 1 | 2021 | 15 | 0.190 |
Why?
|
| Imidazoles | 4 | 1996 | 1169 | 0.190 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1995 | 1534 | 0.190 |
Why?
|
| Hemoglobin A | 3 | 1999 | 84 | 0.190 |
Why?
|
| Enzyme Activators | 1 | 2021 | 56 | 0.190 |
Why?
|
| Anemia, Dyserythropoietic, Congenital | 1 | 2001 | 15 | 0.190 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2016 | 567 | 0.180 |
Why?
|
| Pathology | 2 | 1994 | 270 | 0.180 |
Why?
|
| Thalassemia | 3 | 1999 | 267 | 0.180 |
Why?
|
| Ion Channel Gating | 4 | 1999 | 429 | 0.180 |
Why?
|
| Blood Donors | 2 | 1993 | 343 | 0.180 |
Why?
|
| Rheology | 2 | 2019 | 348 | 0.180 |
Why?
|
| Flow Cytometry | 7 | 2021 | 5902 | 0.180 |
Why?
|
| Female | 78 | 2021 | 397192 | 0.180 |
Why?
|
| Kinetics | 10 | 2005 | 6329 | 0.170 |
Why?
|
| Plasmodium falciparum | 3 | 2015 | 1741 | 0.170 |
Why?
|
| TRPV Cation Channels | 1 | 2021 | 244 | 0.170 |
Why?
|
| Okadaic Acid | 4 | 2006 | 67 | 0.170 |
Why?
|
| Spleen | 3 | 2024 | 2295 | 0.170 |
Why?
|
| Blood Coagulation Tests | 2 | 2019 | 270 | 0.170 |
Why?
|
| Patch-Clamp Techniques | 7 | 2017 | 927 | 0.170 |
Why?
|
| Research Support as Topic | 4 | 2011 | 696 | 0.170 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2019 | 3409 | 0.170 |
Why?
|
| Endothelins | 1 | 1999 | 127 | 0.160 |
Why?
|
| Integrases | 1 | 2022 | 520 | 0.160 |
Why?
|
| Mutation | 15 | 2021 | 30238 | 0.160 |
Why?
|
| Cerebrospinal Fluid | 2 | 2017 | 540 | 0.160 |
Why?
|
| Plasmodium vivax | 1 | 2021 | 203 | 0.160 |
Why?
|
| Malaria, Vivax | 1 | 2021 | 168 | 0.160 |
Why?
|
| Oxygen | 7 | 2015 | 4270 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 23 | 2019 | 22379 | 0.160 |
Why?
|
| Phagocytosis | 1 | 2024 | 1530 | 0.160 |
Why?
|
| Mice, Knockout | 16 | 2021 | 14488 | 0.160 |
Why?
|
| Enzyme Inhibitors | 7 | 2013 | 3728 | 0.160 |
Why?
|
| Industry | 5 | 2011 | 362 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2021 | 253 | 0.160 |
Why?
|
| Iron Chelating Agents | 2 | 1999 | 141 | 0.150 |
Why?
|
| Leukocyte Count | 5 | 2019 | 1609 | 0.150 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2019 | 540 | 0.150 |
Why?
|
| Hypertonic Solutions | 3 | 2006 | 82 | 0.150 |
Why?
|
| Blood Viscosity | 1 | 2018 | 125 | 0.150 |
Why?
|
| Biomedical Research | 8 | 2012 | 3463 | 0.150 |
Why?
|
| Injections, Intravenous | 4 | 2012 | 1377 | 0.150 |
Why?
|
| Host-Parasite Interactions | 3 | 2015 | 303 | 0.150 |
Why?
|
| Kidney Failure, Chronic | 3 | 2006 | 2496 | 0.150 |
Why?
|
| Cell Membrane Permeability | 8 | 2001 | 571 | 0.150 |
Why?
|
| Ionophores | 4 | 2011 | 108 | 0.150 |
Why?
|
| Acoustics | 1 | 2019 | 244 | 0.150 |
Why?
|
| Glutamine | 1 | 2020 | 577 | 0.140 |
Why?
|
| Furosemide | 7 | 1988 | 174 | 0.140 |
Why?
|
| Membrane Potentials | 6 | 2019 | 1090 | 0.140 |
Why?
|
| Mice, Inbred DBA | 5 | 2010 | 624 | 0.140 |
Why?
|
| Rabbits | 10 | 2012 | 4772 | 0.140 |
Why?
|
| Crosses, Genetic | 4 | 2010 | 752 | 0.140 |
Why?
|
| Globins | 4 | 1997 | 405 | 0.140 |
Why?
|
| Peptides | 4 | 2010 | 4354 | 0.140 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2014 | 789 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 386 | 0.140 |
Why?
|
| Iron, Dietary | 1 | 2017 | 148 | 0.140 |
Why?
|
| src-Family Kinases | 4 | 2008 | 539 | 0.140 |
Why?
|
| Phenylhydrazines | 2 | 1994 | 28 | 0.140 |
Why?
|
| Hypertension, Pulmonary | 1 | 2008 | 1605 | 0.140 |
Why?
|
| Brain Damage, Chronic | 1 | 1997 | 265 | 0.130 |
Why?
|
| Antioxidants | 1 | 2004 | 1673 | 0.130 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 879 | 0.130 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 279 | 0.130 |
Why?
|
| Cell Fractionation | 1 | 2016 | 247 | 0.130 |
Why?
|
| Adult | 46 | 2024 | 223646 | 0.130 |
Why?
|
| Trophozoites | 1 | 2015 | 11 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 7454 | 0.130 |
Why?
|
| Drug Industry | 3 | 2010 | 791 | 0.130 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 183 | 0.130 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2024 | 1613 | 0.130 |
Why?
|
| Child, Preschool | 14 | 2021 | 42669 | 0.130 |
Why?
|
| Plasmodium yoelii | 1 | 2015 | 41 | 0.130 |
Why?
|
| Itraconazole | 1 | 1995 | 43 | 0.130 |
Why?
|
| Quinolines | 1 | 2021 | 772 | 0.130 |
Why?
|
| Calcium Channels | 2 | 2010 | 623 | 0.120 |
Why?
|
| 2,3-Diphosphoglycerate | 1 | 2014 | 13 | 0.120 |
Why?
|
| Receptors, Drug | 1 | 1995 | 157 | 0.120 |
Why?
|
| Blood Coagulation | 2 | 2019 | 1162 | 0.120 |
Why?
|
| Species Specificity | 4 | 2013 | 2415 | 0.120 |
Why?
|
| Rubidium | 5 | 2011 | 121 | 0.120 |
Why?
|
| Diarrhea | 2 | 2021 | 1320 | 0.120 |
Why?
|
| Receptor, TIE-2 | 1 | 2015 | 183 | 0.120 |
Why?
|
| Kidney Diseases | 4 | 2018 | 2100 | 0.120 |
Why?
|
| Malaria, Falciparum | 2 | 2015 | 1077 | 0.120 |
Why?
|
| Delivery of Health Care | 1 | 2012 | 5367 | 0.120 |
Why?
|
| Body Water | 4 | 2001 | 340 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 3671 | 0.120 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 20227 | 0.120 |
Why?
|
| Isotonic Solutions | 2 | 2006 | 119 | 0.120 |
Why?
|
| Fibrinogen | 2 | 1998 | 891 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2002 | 1247 | 0.110 |
Why?
|
| Pyridones | 2 | 1999 | 819 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2018 | 1497 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 1995 | 296 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2015 | 23645 | 0.110 |
Why?
|
| Hypophosphatemia | 1 | 2014 | 93 | 0.110 |
Why?
|
| Mutagenesis | 2 | 2017 | 1228 | 0.110 |
Why?
|
| Child | 20 | 2021 | 80917 | 0.110 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 136 | 0.110 |
Why?
|
| Blood Preservation | 1 | 2014 | 169 | 0.110 |
Why?
|
| Phylogeny | 1 | 2021 | 2843 | 0.110 |
Why?
|
| Electrolytes | 2 | 1985 | 279 | 0.110 |
Why?
|
| Immunoassay | 1 | 1997 | 746 | 0.110 |
Why?
|
| Lithium | 6 | 1993 | 600 | 0.110 |
Why?
|
| Endothelin-1 | 3 | 2015 | 296 | 0.110 |
Why?
|
| Adolescent | 20 | 2021 | 89169 | 0.110 |
Why?
|
| Protein Kinase C | 3 | 2004 | 1207 | 0.110 |
Why?
|
| Equipment Design | 1 | 2021 | 3522 | 0.110 |
Why?
|
| Sirtuin 1 | 1 | 2014 | 247 | 0.100 |
Why?
|
| Priapism | 1 | 2012 | 28 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 155 | 0.100 |
Why?
|
| History, 21st Century | 2 | 2016 | 1573 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2008 | 9384 | 0.100 |
Why?
|
| Renal Replacement Therapy | 1 | 2014 | 282 | 0.100 |
Why?
|
| Mice, Mutant Strains | 4 | 2012 | 1754 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2819 | 0.100 |
Why?
|
| Immersion | 1 | 1992 | 37 | 0.100 |
Why?
|
| Stem Cells | 2 | 2015 | 3537 | 0.100 |
Why?
|
| Alleles | 4 | 2018 | 6894 | 0.100 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 2744 | 0.100 |
Why?
|
| Docosahexaenoic Acids | 1 | 2018 | 914 | 0.100 |
Why?
|
| Zoonoses | 1 | 2013 | 180 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2012 | 313 | 0.100 |
Why?
|
| Infant, Premature, Diseases | 1 | 1997 | 712 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2015 | 13014 | 0.090 |
Why?
|
| Calcimycin | 4 | 2022 | 214 | 0.090 |
Why?
|
| Hemochromatosis | 2 | 2008 | 175 | 0.090 |
Why?
|
| Bone Marrow | 2 | 2021 | 2935 | 0.090 |
Why?
|
| Boston | 1 | 2024 | 9374 | 0.090 |
Why?
|
| Chemistry, Clinical | 3 | 2011 | 64 | 0.090 |
Why?
|
| Erythroid Precursor Cells | 5 | 2019 | 211 | 0.090 |
Why?
|
| Skin Ulcer | 1 | 2012 | 130 | 0.090 |
Why?
|
| Cytokines | 3 | 2018 | 7453 | 0.090 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2024 | 1399 | 0.090 |
Why?
|
| Mice, Inbred C3H | 2 | 2010 | 915 | 0.090 |
Why?
|
| Receptors, Endothelin | 2 | 2002 | 56 | 0.090 |
Why?
|
| Receptor, Endothelin B | 2 | 2002 | 46 | 0.090 |
Why?
|
| Mice, Inbred A | 1 | 2010 | 245 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2016 | 2766 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 4 | 2012 | 238 | 0.090 |
Why?
|
| Pathology, Clinical | 2 | 2006 | 375 | 0.090 |
Why?
|
| Heme | 1 | 2012 | 316 | 0.090 |
Why?
|
| Family | 2 | 2019 | 3209 | 0.090 |
Why?
|
| Hydrogen | 2 | 2006 | 171 | 0.090 |
Why?
|
| Dipyridamole | 2 | 2010 | 143 | 0.090 |
Why?
|
| Microwaves | 1 | 1992 | 184 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2021 | 3591 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2012 | 292 | 0.090 |
Why?
|
| Infant | 11 | 2021 | 36535 | 0.090 |
Why?
|
| Laboratories | 2 | 2011 | 463 | 0.090 |
Why?
|
| Spider Venoms | 1 | 2010 | 44 | 0.090 |
Why?
|
| Young Adult | 8 | 2021 | 60066 | 0.090 |
Why?
|
| Chemokine CCL5 | 2 | 2002 | 214 | 0.090 |
Why?
|
| Sensitivity and Specificity | 6 | 2017 | 14729 | 0.090 |
Why?
|
| Milk Proteins | 2 | 2001 | 161 | 0.080 |
Why?
|
| Base Sequence | 12 | 2019 | 12421 | 0.080 |
Why?
|
| Polymorphism, Genetic | 3 | 2015 | 4249 | 0.080 |
Why?
|
| Vascular Malformations | 1 | 2015 | 469 | 0.080 |
Why?
|
| Electric Conductivity | 3 | 2008 | 407 | 0.080 |
Why?
|
| Macrophages | 1 | 2024 | 5799 | 0.080 |
Why?
|
| Rubidium Radioisotopes | 3 | 2009 | 97 | 0.080 |
Why?
|
| Biological Transport, Active | 4 | 1998 | 323 | 0.080 |
Why?
|
| Nystatin | 3 | 2011 | 22 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2015 | 1110 | 0.080 |
Why?
|
| Leukocytes | 1 | 2017 | 2035 | 0.080 |
Why?
|
| Financing, Organized | 1 | 2010 | 203 | 0.080 |
Why?
|
| Reference Standards | 3 | 2021 | 1014 | 0.080 |
Why?
|
| Mice, Inbred Strains | 4 | 2005 | 1765 | 0.080 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 1133 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1728 | 0.080 |
Why?
|
| Antimalarials | 1 | 2015 | 909 | 0.080 |
Why?
|
| Research Report | 1 | 2012 | 369 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2271 | 0.080 |
Why?
|
| Erythrocyte Aggregation | 2 | 2006 | 35 | 0.080 |
Why?
|
| Valinomycin | 1 | 2008 | 17 | 0.080 |
Why?
|
| Plasma | 1 | 1992 | 585 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2005 | 1327 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2015 | 1162 | 0.080 |
Why?
|
| Academies and Institutes | 1 | 2011 | 326 | 0.080 |
Why?
|
| Pain | 2 | 2020 | 5100 | 0.080 |
Why?
|
| Acidosis, Renal Tubular | 2 | 1998 | 50 | 0.080 |
Why?
|
| Water | 4 | 2015 | 1421 | 0.080 |
Why?
|
| Rolipram | 1 | 2008 | 24 | 0.080 |
Why?
|
| Renal Dialysis | 3 | 2004 | 1791 | 0.080 |
Why?
|
| Oxidation-Reduction | 4 | 2012 | 2227 | 0.080 |
Why?
|
| Papio | 2 | 2007 | 671 | 0.080 |
Why?
|
| Sirolimus | 1 | 2015 | 1540 | 0.080 |
Why?
|
| Arginine | 2 | 2006 | 932 | 0.070 |
Why?
|
| Homeostasis | 3 | 2018 | 3348 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 3814 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 1361 | 0.070 |
Why?
|
| Internship and Residency | 3 | 2006 | 5953 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 662 | 0.070 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 3114 | 0.070 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 8054 | 0.070 |
Why?
|
| Curriculum | 2 | 2006 | 3782 | 0.070 |
Why?
|
| Endothelium, Vascular | 5 | 2015 | 4427 | 0.070 |
Why?
|
| Substance-Related Disorders | 2 | 2000 | 4423 | 0.070 |
Why?
|
| Cells, Cultured | 9 | 2022 | 19015 | 0.070 |
Why?
|
| Dialysis | 1 | 2006 | 72 | 0.070 |
Why?
|
| Treatment Outcome | 7 | 2021 | 65371 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2023 | 4755 | 0.070 |
Why?
|
| Charybdotoxin | 3 | 1997 | 23 | 0.070 |
Why?
|
| Sulfates | 4 | 2011 | 379 | 0.070 |
Why?
|
| Infant, Newborn | 5 | 2011 | 26422 | 0.070 |
Why?
|
| Membrane Transport Modulators | 1 | 2006 | 24 | 0.070 |
Why?
|
| Pneumonia | 1 | 2018 | 2163 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 979 | 0.070 |
Why?
|
| Structure-Activity Relationship | 4 | 2016 | 3055 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2012 | 812 | 0.070 |
Why?
|
| Growth Inhibitors | 2 | 1999 | 375 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 4 | 2010 | 6231 | 0.070 |
Why?
|
| Carbon Monoxide | 1 | 2010 | 560 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2021 | 3447 | 0.070 |
Why?
|
| Cross-Linking Reagents | 1 | 2009 | 693 | 0.060 |
Why?
|
| ROC Curve | 3 | 2014 | 3628 | 0.060 |
Why?
|
| Cerebral Hemorrhage | 1 | 1997 | 2655 | 0.060 |
Why?
|
| Drug Evaluation | 2 | 2006 | 642 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 1312 | 0.060 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 2 | 2017 | 17 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 2007 | 4620 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1805 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 13676 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 216 | 0.060 |
Why?
|
| Heterozygote | 4 | 2017 | 2798 | 0.060 |
Why?
|
| Peroxynitrous Acid | 1 | 2005 | 40 | 0.060 |
Why?
|
| Cell Adhesion | 3 | 2011 | 3096 | 0.060 |
Why?
|
| Furaldehyde | 1 | 2005 | 5 | 0.060 |
Why?
|
| Protein Phosphatase 1 | 1 | 2005 | 135 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2062 | 0.060 |
Why?
|
| Hydroxyethylrutoside | 1 | 2004 | 4 | 0.060 |
Why?
|
| Anemia, Sideroblastic | 2 | 2012 | 106 | 0.060 |
Why?
|
| Temperature | 1 | 1992 | 2234 | 0.060 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1999 | 298 | 0.060 |
Why?
|
| Molecular Sequence Data | 10 | 2013 | 17622 | 0.060 |
Why?
|
| Annexins | 1 | 2004 | 40 | 0.060 |
Why?
|
| Spectrin | 3 | 2002 | 176 | 0.060 |
Why?
|
| Gene Targeting | 4 | 2004 | 841 | 0.060 |
Why?
|
| Platelet Count | 2 | 2005 | 787 | 0.060 |
Why?
|
| Adolescent Medicine | 1 | 2005 | 73 | 0.060 |
Why?
|
| Amino Acid Substitution | 3 | 2016 | 1743 | 0.060 |
Why?
|
| Publishing | 1 | 2012 | 837 | 0.060 |
Why?
|
| Genome-Wide Association Study | 3 | 2023 | 12795 | 0.060 |
Why?
|
| Receptors, Transferrin | 2 | 2003 | 300 | 0.060 |
Why?
|
| Codon | 3 | 2016 | 599 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2005 | 8317 | 0.060 |
Why?
|
| Lipoproteins, HDL | 2 | 2002 | 682 | 0.060 |
Why?
|
| Renin | 2 | 1983 | 648 | 0.060 |
Why?
|
| Time Factors | 10 | 2019 | 40218 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 2298 | 0.050 |
Why?
|
| Forecasting | 1 | 2012 | 2945 | 0.050 |
Why?
|
| Pedigree | 4 | 2014 | 4539 | 0.050 |
Why?
|
| Blood Cells | 1 | 2005 | 309 | 0.050 |
Why?
|
| Chromosomes | 1 | 2006 | 578 | 0.050 |
Why?
|
| Platelet Aggregation | 1 | 2006 | 769 | 0.050 |
Why?
|
| Xenopus laevis | 3 | 2013 | 967 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 633 | 0.050 |
Why?
|
| Acetic Acid | 1 | 2022 | 59 | 0.050 |
Why?
|
| K562 Cells | 2 | 2015 | 644 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 414 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2013 | 2650 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4206 | 0.050 |
Why?
|
| Suramin | 1 | 2022 | 34 | 0.050 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 1942 | 0.050 |
Why?
|
| Amino Acid Sequence | 7 | 2019 | 13421 | 0.050 |
Why?
|
| Cell Differentiation | 7 | 2021 | 11669 | 0.050 |
Why?
|
| Probenecid | 1 | 2022 | 73 | 0.050 |
Why?
|
| Chloride Channels | 2 | 2001 | 221 | 0.050 |
Why?
|
| Gene Deletion | 3 | 2021 | 2675 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 8080 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2008 | 2433 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2008 | 4146 | 0.050 |
Why?
|
| Hypotonic Solutions | 3 | 1998 | 48 | 0.050 |
Why?
|
| Platelet Activating Factor | 1 | 2002 | 143 | 0.050 |
Why?
|
| Calcium Signaling | 2 | 2019 | 737 | 0.050 |
Why?
|
| Cell Survival | 4 | 2019 | 5777 | 0.050 |
Why?
|
| Bilirubin | 2 | 2012 | 438 | 0.050 |
Why?
|
| False Positive Reactions | 2 | 2000 | 963 | 0.050 |
Why?
|
| Middle Aged | 20 | 2024 | 223492 | 0.050 |
Why?
|
| Phthalic Acids | 1 | 2006 | 487 | 0.050 |
Why?
|
| Phenotype | 8 | 2019 | 16726 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 1563 | 0.050 |
Why?
|
| Benzaldehydes | 1 | 2021 | 59 | 0.050 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2002 | 283 | 0.050 |
Why?
|
| Permeability | 2 | 2021 | 725 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1169 | 0.050 |
Why?
|
| Trans-Activators | 2 | 2001 | 2857 | 0.050 |
Why?
|
| Boxing | 1 | 2000 | 17 | 0.040 |
Why?
|
| Track and Field | 1 | 2000 | 16 | 0.040 |
Why?
|
| Dinucleotide Repeats | 1 | 2000 | 28 | 0.040 |
Why?
|
| Stroke | 1 | 2023 | 9755 | 0.040 |
Why?
|
| Kidney Concentrating Ability | 1 | 2000 | 34 | 0.040 |
Why?
|
| Urea | 1 | 2003 | 448 | 0.040 |
Why?
|
| Oxyhemoglobins | 3 | 2014 | 213 | 0.040 |
Why?
|
| Tyrosine | 1 | 2005 | 1427 | 0.040 |
Why?
|
| Neoplasms | 2 | 2008 | 22371 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2011 | 3711 | 0.040 |
Why?
|
| Hypertension | 7 | 1987 | 8616 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2022 | 4283 | 0.040 |
Why?
|
| Leukemia, Erythroblastic, Acute | 2 | 1998 | 176 | 0.040 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2024 | 565 | 0.040 |
Why?
|
| Vitamin E | 1 | 2004 | 874 | 0.040 |
Why?
|
| Marine Toxins | 1 | 1999 | 24 | 0.040 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22291 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2019 | 18065 | 0.040 |
Why?
|
| DNA, Complementary | 6 | 1999 | 1989 | 0.040 |
Why?
|
| Magnesium Deficiency | 2 | 1997 | 48 | 0.040 |
Why?
|
| Point Mutation | 2 | 1995 | 1596 | 0.040 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2001 | 111 | 0.040 |
Why?
|
| Clinical Chemistry Tests | 1 | 2020 | 59 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 1169 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2020 | 15454 | 0.040 |
Why?
|
| Genotype | 4 | 2023 | 13045 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2000 | 420 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2002 | 491 | 0.040 |
Why?
|
| Adenosine Triphosphate | 3 | 2022 | 2004 | 0.040 |
Why?
|
| Swimming | 1 | 2000 | 209 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 2149 | 0.040 |
Why?
|
| Methylation | 1 | 2002 | 1078 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2001 | 526 | 0.040 |
Why?
|
| Apyrase | 1 | 2022 | 376 | 0.040 |
Why?
|
| Mitochondria | 1 | 2012 | 3681 | 0.040 |
Why?
|
| Pediatrics | 2 | 2006 | 3629 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2013 | 2748 | 0.040 |
Why?
|
| Bicycling | 1 | 2000 | 177 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2019 | 192 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 2001 | 9615 | 0.040 |
Why?
|
| Solubility | 1 | 2001 | 1083 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2015 | 8741 | 0.040 |
Why?
|
| Blood Transfusion | 3 | 2021 | 1309 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2000 | 331 | 0.040 |
Why?
|
| Threonine | 1 | 1999 | 273 | 0.040 |
Why?
|
| DNA Primers | 3 | 2007 | 2828 | 0.040 |
Why?
|
| Oscillometry | 1 | 2019 | 151 | 0.040 |
Why?
|
| Naphthalenes | 1 | 1999 | 198 | 0.040 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 652 | 0.040 |
Why?
|
| Viscosity | 1 | 2019 | 334 | 0.040 |
Why?
|
| Teaching | 1 | 2006 | 1171 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2007 | 2885 | 0.040 |
Why?
|
| 5-Aminolevulinate Synthetase | 1 | 1998 | 64 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 2892 | 0.040 |
Why?
|
| Oxazoles | 1 | 1999 | 199 | 0.040 |
Why?
|
| gamma-Globins | 1 | 2019 | 105 | 0.040 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1999 | 238 | 0.040 |
Why?
|
| Ribavirin | 1 | 2000 | 395 | 0.040 |
Why?
|
| Anemia, Megaloblastic | 1 | 1998 | 24 | 0.040 |
Why?
|
| Aged | 9 | 2021 | 171504 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 2909 | 0.040 |
Why?
|
| Zebrafish | 4 | 2012 | 3035 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2011 | 12465 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2005 | 4528 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 267 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2014 | 2937 | 0.040 |
Why?
|
| Ischemia | 1 | 2006 | 1900 | 0.040 |
Why?
|
| Proteins | 1 | 2012 | 6009 | 0.040 |
Why?
|
| Anions | 2 | 1988 | 137 | 0.040 |
Why?
|
| Meningococcal Infections | 1 | 1998 | 78 | 0.040 |
Why?
|
| Phenylurea Compounds | 1 | 2001 | 531 | 0.040 |
Why?
|
| Protein C | 1 | 1998 | 134 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2020 | 81762 | 0.040 |
Why?
|
| Streptokinase | 1 | 1997 | 186 | 0.040 |
Why?
|
| Hemoglobin C | 2 | 1989 | 21 | 0.040 |
Why?
|
| Genome, Viral | 1 | 2021 | 674 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 2015 | 2363 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 1997 | 227 | 0.040 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 1997 | 91 | 0.040 |
Why?
|
| Cations, Divalent | 2 | 1987 | 167 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 2000 | 326 | 0.040 |
Why?
|
| Elasticity | 1 | 2019 | 656 | 0.030 |
Why?
|
| Xenopus | 4 | 2000 | 711 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2002 | 778 | 0.030 |
Why?
|
| Genome | 3 | 2000 | 1754 | 0.030 |
Why?
|
| Drug Therapy, Combination | 4 | 2021 | 6316 | 0.030 |
Why?
|
| Thrombelastography | 1 | 2019 | 194 | 0.030 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1997 | 130 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2007 | 7608 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 3858 | 0.030 |
Why?
|
| United States | 6 | 2017 | 73039 | 0.030 |
Why?
|
| Athletic Performance | 1 | 2017 | 113 | 0.030 |
Why?
|
| Sound | 1 | 2018 | 261 | 0.030 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 108 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1997 | 324 | 0.030 |
Why?
|
| Cloning, Molecular | 5 | 2000 | 4168 | 0.030 |
Why?
|
| Cytosol | 1 | 1999 | 887 | 0.030 |
Why?
|
| Trace Elements | 1 | 2018 | 193 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2001 | 1406 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2013 | 10760 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2002 | 1183 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2002 | 1194 | 0.030 |
Why?
|
| Cations, Monovalent | 2 | 2013 | 24 | 0.030 |
Why?
|
| Food, Fortified | 1 | 1997 | 189 | 0.030 |
Why?
|
| Uremia | 1 | 1997 | 202 | 0.030 |
Why?
|
| Menstruation | 1 | 2017 | 310 | 0.030 |
Why?
|
| Sodium Channels | 1 | 1998 | 341 | 0.030 |
Why?
|
| Research Design | 1 | 2012 | 6211 | 0.030 |
Why?
|
| Family Health | 1 | 2001 | 1255 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1995 | 94 | 0.030 |
Why?
|
| Imidazoline Receptors | 1 | 1995 | 13 | 0.030 |
Why?
|
| Vitamins | 1 | 2004 | 1638 | 0.030 |
Why?
|
| Bone Marrow Diseases | 1 | 1998 | 234 | 0.030 |
Why?
|
| Serine | 1 | 1999 | 831 | 0.030 |
Why?
|
| Acetonitriles | 1 | 1995 | 55 | 0.030 |
Why?
|
| Cell Line | 6 | 2016 | 15597 | 0.030 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 170 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 1418 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-hck | 2 | 2005 | 46 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1367 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2006 | 4194 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1998 | 855 | 0.030 |
Why?
|
| Benzofurans | 1 | 1996 | 138 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2017 | 1338 | 0.030 |
Why?
|
| Cohort Studies | 4 | 2021 | 41754 | 0.030 |
Why?
|
| Volatilization | 1 | 2014 | 76 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2004 | 4568 | 0.030 |
Why?
|
| Pyrazines | 1 | 2021 | 1205 | 0.030 |
Why?
|
| Tetrazoles | 1 | 2001 | 923 | 0.030 |
Why?
|
| Monomethylhydrazine | 1 | 1994 | 1 | 0.030 |
Why?
|
| Blood Platelets | 1 | 2005 | 2479 | 0.030 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2014 | 110 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2014 | 248 | 0.030 |
Why?
|
| Proteomics | 1 | 2008 | 3912 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 1040 | 0.030 |
Why?
|
| Interleukins | 1 | 1999 | 796 | 0.030 |
Why?
|
| Portal Vein | 1 | 1997 | 435 | 0.030 |
Why?
|
| Centrifugation | 1 | 2014 | 122 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2023 | 1422 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2006 | 2763 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 4 | 2001 | 6082 | 0.030 |
Why?
|
| Neurotoxins | 1 | 1995 | 240 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2005 | 6340 | 0.030 |
Why?
|
| alpha-Globins | 1 | 2014 | 20 | 0.030 |
Why?
|
| Freeze Fracturing | 1 | 1994 | 70 | 0.030 |
Why?
|
| Guidelines as Topic | 2 | 2011 | 1397 | 0.030 |
Why?
|
| Oocytes | 3 | 2009 | 1172 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 2862 | 0.030 |
Why?
|
| Neutrophils | 2 | 2018 | 3786 | 0.030 |
Why?
|
| Zambia | 1 | 2014 | 273 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 2 | 1991 | 105 | 0.030 |
Why?
|
| Splenectomy | 1 | 2015 | 392 | 0.030 |
Why?
|
| Isoenzymes | 1 | 1998 | 1688 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1798 | 0.030 |
Why?
|
| Adult Children | 1 | 2014 | 104 | 0.030 |
Why?
|
| Blood Banks | 1 | 2014 | 108 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3589 | 0.030 |
Why?
|
| Models, Biological | 2 | 2024 | 9495 | 0.030 |
Why?
|
| RNA | 3 | 1999 | 2720 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1998 | 1081 | 0.030 |
Why?
|
| Peroxiredoxins | 1 | 2013 | 51 | 0.030 |
Why?
|
| Feedback | 1 | 1997 | 799 | 0.030 |
Why?
|
| Antigens | 1 | 1999 | 1442 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2022 | 5797 | 0.030 |
Why?
|
| Cell Shape | 1 | 2014 | 371 | 0.030 |
Why?
|
| Ferrous Compounds | 1 | 1993 | 41 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1999 | 1196 | 0.030 |
Why?
|
| Catalase | 1 | 2013 | 215 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2002 | 2451 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 642 | 0.030 |
Why?
|
| Piperidines | 1 | 2002 | 1667 | 0.030 |
Why?
|
| Bucladesine | 1 | 2012 | 118 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 1890 | 0.030 |
Why?
|
| 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1989 | 33 | 0.030 |
Why?
|
| Methazolamide | 2 | 1989 | 9 | 0.030 |
Why?
|
| Ferrochelatase | 1 | 2012 | 47 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 2006 | 12800 | 0.030 |
Why?
|
| Total Quality Management | 1 | 1994 | 265 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2018 | 24315 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 2015 | 428 | 0.030 |
Why?
|
| Kidney | 4 | 2009 | 7064 | 0.030 |
Why?
|
| Drug Resistance | 2 | 1995 | 1599 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 1997 | 1493 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 1994 | 687 | 0.030 |
Why?
|
| Financial Management | 1 | 1994 | 161 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2003 | 3583 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1219 | 0.030 |
Why?
|
| Isoelectric Point | 1 | 1992 | 76 | 0.030 |
Why?
|
| Sheep | 3 | 1990 | 1451 | 0.020 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2012 | 185 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2014 | 714 | 0.020 |
Why?
|
| Intestinal Mucosa | 3 | 2000 | 3044 | 0.020 |
Why?
|
| Cell Division | 2 | 2000 | 4473 | 0.020 |
Why?
|
| Calorimetry | 1 | 1992 | 132 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2012 | 250 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2015 | 313 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2012 | 557 | 0.020 |
Why?
|
| Hepatitis C, Chronic | 1 | 2000 | 1032 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 1995 | 644 | 0.020 |
Why?
|
| Cytoskeleton | 2 | 2012 | 1179 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1997 | 1165 | 0.020 |
Why?
|
| Nitrates | 1 | 1993 | 260 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2016 | 5403 | 0.020 |
Why?
|
| Liver | 2 | 2019 | 7577 | 0.020 |
Why?
|
| Societies | 1 | 2012 | 107 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4120 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1896 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 412 | 0.020 |
Why?
|
| Shock, Septic | 1 | 1998 | 774 | 0.020 |
Why?
|
| Quality Control | 1 | 1994 | 836 | 0.020 |
Why?
|
| Gestational Age | 1 | 2000 | 3621 | 0.020 |
Why?
|
| Malaria | 1 | 2021 | 1249 | 0.020 |
Why?
|
| Mesylates | 1 | 2011 | 37 | 0.020 |
Why?
|
| Veins | 1 | 2015 | 769 | 0.020 |
Why?
|
| Treatment Failure | 1 | 1997 | 2661 | 0.020 |
Why?
|
| Ethics Committees | 1 | 2010 | 51 | 0.020 |
Why?
|
| Freezing | 1 | 1992 | 311 | 0.020 |
Why?
|
| Drug Interactions | 1 | 1995 | 1419 | 0.020 |
Why?
|
| Rural Health Services | 1 | 2014 | 394 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 1995 | 842 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1997 | 2357 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 14164 | 0.020 |
Why?
|
| Methylamines | 1 | 2011 | 136 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 687 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 2560 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2008 | 5536 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2021 | 2028 | 0.020 |
Why?
|
| Complement Activation | 2 | 1989 | 447 | 0.020 |
Why?
|
| Publication Bias | 1 | 2010 | 158 | 0.020 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2010 | 169 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2006 | 11928 | 0.020 |
Why?
|
| Scientific Misconduct | 1 | 2010 | 77 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 1993 | 529 | 0.020 |
Why?
|
| Transfection | 2 | 2013 | 5755 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 2 | 2001 | 268 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1998 | 2709 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 5703 | 0.020 |
Why?
|
| Biological Availability | 2 | 2005 | 389 | 0.020 |
Why?
|
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 1989 | 22 | 0.020 |
Why?
|
| RNA, Complementary | 1 | 2009 | 46 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2540 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 1995 | 964 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2015 | 1004 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 3623 | 0.020 |
Why?
|
| bcl-X Protein | 2 | 2001 | 412 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 1667 | 0.020 |
Why?
|
| Triglycerides | 2 | 1995 | 2464 | 0.020 |
Why?
|
| Inflammation | 1 | 2008 | 10873 | 0.020 |
Why?
|
| Fetal Blood | 1 | 2015 | 1361 | 0.020 |
Why?
|
| Intestines | 1 | 1997 | 1909 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 809 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2009 | 636 | 0.020 |
Why?
|
| Chloride-Bicarbonate Antiporters | 2 | 1998 | 103 | 0.020 |
Why?
|
| Colon | 1 | 1996 | 1801 | 0.020 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 2055 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2015 | 1250 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2016 | 3956 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2008 | 156 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2019 | 2982 | 0.020 |
Why?
|
| Particle Size | 1 | 2012 | 1649 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2014 | 12168 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 1083 | 0.020 |
Why?
|
| Prevalence | 3 | 2017 | 15869 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 77 | 0.020 |
Why?
|
| Troponin I | 1 | 2012 | 662 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2000 | 3073 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2014 | 1247 | 0.020 |
Why?
|
| Gene Expression | 2 | 2016 | 7598 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1676 | 0.020 |
Why?
|
| Apoptosis | 2 | 2001 | 9523 | 0.020 |
Why?
|
| Graft Survival | 1 | 1998 | 3887 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 2173 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1730 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2010 | 1340 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2457 | 0.020 |
Why?
|
| Mice, Inbred NZB | 1 | 2006 | 57 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 3610 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 379 | 0.020 |
Why?
|
| Bradykinin | 1 | 1986 | 205 | 0.020 |
Why?
|
| Folic Acid | 1 | 1993 | 1337 | 0.020 |
Why?
|
| Glycosylation | 2 | 1999 | 1100 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
| Mice, Inbred MRL lpr | 1 | 2006 | 158 | 0.020 |
Why?
|
| Electrophysiology | 2 | 2004 | 1266 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 432 | 0.020 |
Why?
|
| Molsidomine | 1 | 2005 | 22 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2000 | 2300 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2007 | 2089 | 0.020 |
Why?
|
| Intracellular Fluid | 2 | 1996 | 201 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 3327 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2011 | 1972 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 1988 | 738 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 3 | 1998 | 6124 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2014 | 2575 | 0.020 |
Why?
|
| Lod Score | 1 | 2005 | 600 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2007 | 899 | 0.020 |
Why?
|
| DNA | 2 | 2000 | 7214 | 0.010 |
Why?
|
| Markov Chains | 1 | 2008 | 979 | 0.010 |
Why?
|
| Vasopressins | 1 | 1986 | 358 | 0.010 |
Why?
|
| Homozygote | 1 | 1989 | 1779 | 0.010 |
Why?
|
| Hypertension, Renal | 2 | 1986 | 135 | 0.010 |
Why?
|
| Autoanalysis | 1 | 2004 | 70 | 0.010 |
Why?
|
| Ergotamines | 1 | 1984 | 4 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 5804 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1987 | 542 | 0.010 |
Why?
|
| Blood Volume | 1 | 2005 | 545 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2012 | 1406 | 0.010 |
Why?
|
| Exons | 2 | 2000 | 2394 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2011 | 5027 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 1997 | 39348 | 0.010 |
Why?
|
| Endothelium | 1 | 1986 | 768 | 0.010 |
Why?
|
| Parotid Gland | 1 | 2004 | 178 | 0.010 |
Why?
|
| Animals, Newborn | 2 | 2000 | 2678 | 0.010 |
Why?
|
| Acid-Base Equilibrium | 1 | 1984 | 180 | 0.010 |
Why?
|
| Inheritance Patterns | 1 | 2005 | 344 | 0.010 |
Why?
|
| Prognosis | 2 | 2008 | 30010 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2012 | 1982 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1656 | 0.010 |
Why?
|
| Genome, Human | 1 | 2015 | 4446 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1994 | 1932 | 0.010 |
Why?
|
| Rats | 4 | 2001 | 23760 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 2463 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 3772 | 0.010 |
Why?
|
| Mitosis | 1 | 2007 | 1178 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 943 | 0.010 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2002 | 85 | 0.010 |
Why?
|
| Medical Staff, Hospital | 1 | 2006 | 603 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2005 | 54926 | 0.010 |
Why?
|
| Mice, Inbred AKR | 1 | 2001 | 104 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2633 | 0.010 |
Why?
|
| Receptors, Lipoprotein | 1 | 2002 | 88 | 0.010 |
Why?
|
| Receptors, Scavenger | 1 | 2002 | 123 | 0.010 |
Why?
|
| Exercise | 1 | 2017 | 5955 | 0.010 |
Why?
|
| Health Personnel | 1 | 2014 | 3385 | 0.010 |
Why?
|
| E2F4 Transcription Factor | 1 | 2000 | 33 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 1715 | 0.010 |
Why?
|
| Phagosomes | 1 | 2002 | 198 | 0.010 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2000 | 41 | 0.010 |
Why?
|
| Child Health Services | 1 | 2006 | 645 | 0.010 |
Why?
|
| Hemorrhage | 1 | 1993 | 3467 | 0.010 |
Why?
|
| Staurosporine | 1 | 2001 | 241 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5717 | 0.010 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 2000 | 33 | 0.010 |
Why?
|
| Chromosome Walking | 1 | 2000 | 26 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 3740 | 0.010 |
Why?
|
| Risk Factors | 4 | 2014 | 74944 | 0.010 |
Why?
|
| Yolk Sac | 1 | 2000 | 79 | 0.010 |
Why?
|
| Drug Administration Schedule | 3 | 1994 | 4860 | 0.010 |
Why?
|
| Hyperlipidemias | 1 | 1985 | 772 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1984 | 744 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2000 | 439 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1986 | 710 | 0.010 |
Why?
|
| Saliva | 1 | 2004 | 853 | 0.010 |
Why?
|
| Poly A | 1 | 1999 | 180 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2008 | 2258 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1999 | 417 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 1057 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 3590 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1999 | 102 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 2000 | 384 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2005 | 10101 | 0.010 |
Why?
|
| Models, Genetic | 2 | 1999 | 3447 | 0.010 |
Why?
|
| Friend murine leukemia virus | 1 | 1998 | 37 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1999 | 363 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1999 | 816 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4580 | 0.010 |
Why?
|
| Enterocytes | 1 | 2000 | 220 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2008 | 1951 | 0.010 |
Why?
|
| Renal Artery | 1 | 1980 | 354 | 0.010 |
Why?
|
| Diet | 1 | 1996 | 8089 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2005 | 1880 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 1999 | 255 | 0.010 |
Why?
|
| Complement C3 | 1 | 2000 | 434 | 0.010 |
Why?
|
| Ligands | 1 | 2005 | 3284 | 0.010 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1997 | 31 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 1550 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1997 | 55 | 0.010 |
Why?
|
| Craniofacial Abnormalities | 1 | 2000 | 320 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 966 | 0.010 |
Why?
|
| Superior Cervical Ganglion | 1 | 1997 | 33 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1999 | 828 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 1065 | 0.010 |
Why?
|
| Survival | 1 | 1998 | 160 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 16045 | 0.010 |
Why?
|
| Opportunistic Infections | 1 | 2000 | 375 | 0.010 |
Why?
|
| Binding Sites | 2 | 1996 | 6020 | 0.010 |
Why?
|
| Prothrombin | 1 | 1998 | 194 | 0.010 |
Why?
|
| Toxins, Biological | 1 | 1997 | 59 | 0.010 |
Why?
|
| 3' Untranslated Regions | 1 | 1999 | 515 | 0.010 |
Why?
|
| 4-Aminopyridine | 1 | 1997 | 81 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1998 | 293 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1997 | 317 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 1997 | 204 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2001 | 1505 | 0.010 |
Why?
|
| Ferrets | 1 | 1997 | 181 | 0.010 |
Why?
|
| Glyburide | 1 | 1997 | 117 | 0.010 |
Why?
|
| Cholesterol | 2 | 2002 | 2914 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2000 | 818 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1998 | 418 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2000 | 910 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 240 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 2000 | 592 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2001 | 916 | 0.010 |
Why?
|
| Interferons | 1 | 2000 | 720 | 0.010 |
Why?
|
| Genes, Recessive | 1 | 1998 | 625 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 1461 | 0.010 |
Why?
|
| Cattle | 2 | 1995 | 3819 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1998 | 785 | 0.010 |
Why?
|
| Endotoxins | 1 | 1998 | 519 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 709 | 0.010 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 1145 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1997 | 392 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1997 | 423 | 0.010 |
Why?
|
| Actins | 1 | 2002 | 2064 | 0.010 |
Why?
|
| Miconazole | 1 | 1994 | 9 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 944 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1995 | 383 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1997 | 677 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1997 | 547 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 2474 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1408 | 0.010 |
Why?
|
| Autophagy | 1 | 2002 | 1349 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 1084 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2000 | 1793 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 1904 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1997 | 1883 | 0.010 |
Why?
|
| Cell Polarity | 1 | 1996 | 639 | 0.010 |
Why?
|
| Sex Factors | 2 | 1986 | 10632 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1997 | 1888 | 0.010 |
Why?
|
| Heart Diseases | 1 | 1986 | 2819 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1998 | 2342 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1997 | 2179 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1470 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1999 | 2094 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2000 | 2932 | 0.010 |
Why?
|
| Creatinine | 1 | 1997 | 1918 | 0.010 |
Why?
|
| Epithelium | 1 | 1996 | 1607 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1995 | 1216 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4415 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1996 | 1760 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1998 | 2603 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 12077 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2000 | 6229 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 1162 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 2014 | 0.010 |
Why?
|
| Placenta | 1 | 2000 | 1725 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 2973 | 0.010 |
Why?
|
| Mice, SCID | 1 | 1995 | 2627 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9538 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 59629 | 0.010 |
Why?
|
| Electrochemistry | 1 | 1989 | 145 | 0.010 |
Why?
|
| Colloids | 1 | 1989 | 125 | 0.010 |
Why?
|
| Pregnancy | 2 | 2004 | 30256 | 0.000 |
Why?
|
| Osmotic Pressure | 1 | 1989 | 137 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1989 | 1310 | 0.000 |
Why?
|
| Neoplastic Stem Cells | 1 | 1995 | 1351 | 0.000 |
Why?
|
| Sodium Chloride | 1 | 1989 | 584 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1996 | 3780 | 0.000 |
Why?
|
| Lactates | 1 | 1987 | 401 | 0.000 |
Why?
|
| Membrane Lipids | 1 | 1987 | 252 | 0.000 |
Why?
|
| Umbilical Veins | 1 | 1986 | 424 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1987 | 454 | 0.000 |
Why?
|
| Odds Ratio | 1 | 1997 | 9669 | 0.000 |
Why?
|
| Dogs | 1 | 1990 | 3845 | 0.000 |
Why?
|
| Obesity | 1 | 1987 | 13090 | 0.000 |
Why?
|
| Vasoconstriction | 1 | 1987 | 592 | 0.000 |
Why?
|
| Radioisotopes | 1 | 1986 | 517 | 0.000 |
Why?
|
| Ergotamine | 1 | 1984 | 7 | 0.000 |
Why?
|
| Escherichia coli | 1 | 1997 | 4214 | 0.000 |
Why?
|
| Aging | 1 | 1983 | 8744 | 0.000 |
Why?
|
| Celiac Artery | 1 | 1984 | 65 | 0.000 |
Why?
|
| Thrombosis | 1 | 1998 | 2957 | 0.000 |
Why?
|
| Mesenteric Arteries | 1 | 1984 | 178 | 0.000 |
Why?
|
| Comorbidity | 1 | 1997 | 10590 | 0.000 |
Why?
|
| Brachial Artery | 1 | 1984 | 373 | 0.000 |
Why?
|
| Lactic Acid | 1 | 1987 | 1140 | 0.000 |
Why?
|
| Phospholipids | 1 | 1985 | 787 | 0.000 |
Why?
|
| Software | 1 | 1995 | 4478 | 0.000 |
Why?
|
| Aorta, Thoracic | 1 | 1986 | 1110 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1997 | 5889 | 0.000 |
Why?
|
| Melanoma | 1 | 1995 | 5706 | 0.000 |
Why?
|
| Lipids | 1 | 1987 | 3343 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1987 | 8543 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1995 | 13586 | 0.000 |
Why?
|
| Age Factors | 1 | 1986 | 18412 | 0.000 |
Why?
|
| Radiography | 1 | 1980 | 6983 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 1982 | 15662 | 0.000 |
Why?
|